Kyu-Don Kim
Corporate Officer/Principal at GENEXINE, INC.
Profile
Kyu-Don Kim is currently the Director of Operations at PT Kalbe Genexine Biologics and the President of the Executive Board at Genexine, Inc. Previously, he worked as the Vice President, Director, and Head of Management at Chong Kun Dang Pharmaceutical Corp.
in 2014.
He holds a doctorate degree from Northern Illinois University.
Kyu-Don Kim active positions
| Companies | Position | Start |
|---|---|---|
| GENEXINE, INC. | Corporate Officer/Principal | - |
PT Kalbe Genexine Biologics
 PT Kalbe Genexine Biologics BiotechnologyHealth Technology PT Kalbe Genexine Biologics is a clinical-stage biotech company based in Jakarta, Indonesia. The Indonesian company specializes in licensing novel biologics and biosimilars in oncology and high-specialty therapeutic areas, as well as contract manufacturing. The company was founded in 2016 and is backed by Kalbe and Genexine, as well as US private equity giant General. The CEO is Sie Djohan. | Chief Operating Officer | - |
Former positions of Kyu-Don Kim
| Companies | Position | End |
|---|---|---|
| CHONG KUN DANG PHARMACEUTICAL CORP. | Chief Executive Officer | - |
Training of Kyu-Don Kim
| Northern Illinois University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| CHONG KUN DANG PHARMACEUTICAL CORP. | Health Technology |
| GENEXINE, INC. | Health Technology |
| Private companies | 1 |
|---|---|
PT Kalbe Genexine Biologics
PT Kalbe Genexine Biologics BiotechnologyHealth Technology PT Kalbe Genexine Biologics is a clinical-stage biotech company based in Jakarta, Indonesia. The Indonesian company specializes in licensing novel biologics and biosimilars in oncology and high-specialty therapeutic areas, as well as contract manufacturing. The company was founded in 2016 and is backed by Kalbe and Genexine, as well as US private equity giant General. The CEO is Sie Djohan. | Health Technology |
- Stock Market
- Insiders
- Kyu-Don Kim
